Acta Neurologica Scandinavica

Volume 62, Issue S80 pp. 46-52

Full Access

Anticonvulsants and mental symptoms

Edward H. Reynolds, 

Edward H. Reynolds

Search for more papers by this author

Edward H. Reynolds, 

Edward H. Reynolds

Search for more papers by this author

First published: December 1980

https://doi.org/10.1111/j.1600-0404.1980.tb02349.x

Citations: 2

References

• Bonnycastle D D, Giarman N J & Paasonen M K: Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. Br J Pharmacol 12: 228–231, 1957.
  10.1111/j.1476-5381.1957.tb00125.x

  CAS PubMed Web of Science® Google Scholar
• Botez M I & Reynolds E H: Folic acid in Neurology, Psychiatry and Internal Medicine. Raven Press. New York 1979.
  Google Scholar
• Botez M I, Young S N, Bachevalier J & Gauthier S: Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature 278: 182–183, 1979.
  10.1038/278182a0

  CAS PubMed Web of Science® Google Scholar
• Chadwick D, Jenner P & Reynolds E H: Serotonin metabolism in human epilepsy. Ann Neurol 1: 218–224, 1977.
  10.1002/ana.410010304

  CAS PubMed Web of Science® Google Scholar
• Chadwick D, Gorrod J W, Jenner P, Marsden C D & Reynolds E H: Functional changes in cerebral 5-hydroxytryptamine metabolism in the mouse induced by anticonvulsant drugs. Br J Pharmacol 62: 115–124, 1978.
  10.1111/j.1476-5381.1978.tb07013.x

  CAS PubMed Web of Science® Google Scholar
• Glaser G H: Diphenylhydantoin toxicity. In: Antiepileptic Drugs, pp 219–226. Eds: D M Woodbury, J K Penry & R P Schmidt Raven Press. New York 1972.
  Google Scholar
• Hutt S J, Jackson P M, Belsham A B & Higgins G: Perceptual-motor behaviour in relation to blood phenobarbitone level. Dev Med Child Neurol 10: 626–632, 1968.
  10.1111/j.1469-8749.1968.tb02947.x

  PubMed Web of Science® Google Scholar
• Ideström C M, Schalling D, Carlquist U & Sjöquist F: Behavioural and psychophysiological studies: acute effects of diphenylhydantoin in relation to plasma levels. Psychol Med 2: 111–120, 1972.
  10.1017/S0033291700040599

  PubMed Web of Science® Google Scholar
• Lascelles P T, Kocen R S & Reynolds E H: The distribution of plasma phenytoin levels in epileptic patients. J Neurol Neurosurg Psychiatry 33: 501–505, 1970.
  10.1136/jnnp.33.4.501

  CAS PubMed Web of Science® Google Scholar
• Lennox W G: Brain injury, drugs and environment as causes of mental decay in epilepsy. Am J Psychiatry 99: 174–180, 1942.
  10.1176/ajp.99.2.174

  Web of Science® Google Scholar
• London D R: Hormonal effects of anticonvulsant drugs. Communication to 11th epilepsy international symposium. Raven Press. New York . In press 1979.
  Google Scholar
• Makki K A, Perucca E & Richens A: Metabolic effects of folic acid replacement therapy in folate deficient epileptic patients. Communication to 11th epilepsy international symposium. Raven Press. New York . In press 1979.
  Google Scholar
• Reynolds E H: Effects of folic acid on the mental state and fit frequency of drug treated epileptic patients. Lancet 1: 1086–1088, 1967.
  10.1016/S0140-6736(67)92654-2

  PubMed Web of Science® Google Scholar
• Reynolds E H: Iatrogenic disorders in epilepsy. In: Modern Trends in Neurology no 5, pp 271–286. Ed: D Williams. Butterworths. London 1970.
  Google Scholar
• Reynolds E H: Chronic antiepileptic toxicity: a review. Epilepsia 16: 319–352, 1975.
  10.1111/j.1528-1157.1975.tb06062.x

  CAS PubMed Web of Science® Google Scholar
• Reynolds E H: Neurological aspects of folate and vitamin B₁₂ metabolism. In: Clinics in Haematology 5: 661–696. Ed: A V Hoffbrand. W B Saunders Co. Philadelphia 1976.
  10.1016/S0308-2261(21)00115-6

  Web of Science® Google Scholar
• Reynolds E H: Chronic toxicity of antiepileptic drugs. In: Advances in Epileptology, pp 340–341. Eds: H Meinardi & A J Rowan Svets & Zeitlinger. Amsterdam 1977.
  Google Scholar
• Reynolds E H: Drug treatment of epilepsy. Lancet 2: 721–725, 1978.
  10.1016/S0140-6736(78)92713-7

  CAS PubMed Web of Science® Google Scholar
• Reynolds E H: Inter-relations between the neurology of vitamin B₁₂ and folic acid deficiency. In: Folic Acid in Neurology, Psychiatry and Internal Medicine. Eds: M I Botez & E H Reynolds Raven Press. New York 1979.
  Google Scholar
• Reynolds E H & Travers R D: Serum anticonvulsant concentrations in epileptic patients with mental symptoms. Br J Psychiatry 124: 440–445, 1974.
  10.1192/bjp.124.5.440

  PubMed Web of Science® Google Scholar
• Reynolds E H & Shorvon S D: Monotherapy or polytherapy for epilepsy Communication to the 11th epilepsy international symposium. Raven Press. New York . In press 1979.
  Google Scholar
• Rosen J A: Dilantin dementia. Trans Am Neurol Assoc 93: 273, 1968.
  PubMed Google Scholar
• Shorvon S D & Reynolds E H: Reduction in polytherapy for epilepsy. Br Med J 2: 1023–1025, 1979.
  10.1136/bmj.2.6197.1023

  PubMed Web of Science® Google Scholar
• Shulman R: Psychiatric aspects of pernicious anaemia: a prospective controlled investigation. Br Med J 3: 266–270, 1966.
  10.1136/bmj.3.5560.266

  CAS Web of Science® Google Scholar
• Stores G: Behavioural effects of antiepileptic drugs. Develop Med Child Neurol 17: 647–658, 1975.
  10.1111/j.1469-8749.1975.tb03536.x

  PubMed Web of Science® Google Scholar
• Trimble M & Reynolds E H: Anticonvulsant drugs and mental symptoms: a review. Psychol Med 6: 168–178, 1976.
  10.1017/S0033291700013726

  Google Scholar
• Turner A J: Relationship between brain folate and monoamine metabolism. In: Folic Acid in Neurology, Psychiatry and Internal Medicine. Eds: M I Botez & E H Reynolds Raven Press. New York 1979.
  Google Scholar

Citing Literature

• 
  All articles  >

• References

• Related

• Information

Close Figure Viewer

Previous FigureNext Figure

Caption

Download PDF